ANI Pharmaceuticals Inc
NASDAQ:ANIP

Watchlist Manager
ANI Pharmaceuticals Inc Logo
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Watchlist
Price: 58.91 USD -1.54% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
ANI Pharmaceuticals Inc?
Write Note

ANI Pharmaceuticals Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ANI Pharmaceuticals Inc
Cash from Operating Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Cash from Operating Activities
$112.6m
CAGR 3-Years
102%
CAGR 5-Years
16%
CAGR 10-Years
46%
Johnson & Johnson
NYSE:JNJ
Cash from Operating Activities
$25.1B
CAGR 3-Years
-1%
CAGR 5-Years
2%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Operating Activities
$15B
CAGR 3-Years
-1%
CAGR 5-Years
12%
CAGR 10-Years
14%
Pfizer Inc
NYSE:PFE
Cash from Operating Activities
$8B
CAGR 3-Years
-37%
CAGR 5-Years
-10%
CAGR 10-Years
-7%
Merck & Co Inc
NYSE:MRK
Cash from Operating Activities
$18.3B
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
4%
Eli Lilly and Co
NYSE:LLY
Cash from Operating Activities
$6B
CAGR 3-Years
-4%
CAGR 5-Years
7%
CAGR 10-Years
2%

See Also

What is ANI Pharmaceuticals Inc's Cash from Operating Activities?
Cash from Operating Activities
112.6m USD

Based on the financial report for Jun 30, 2024, ANI Pharmaceuticals Inc's Cash from Operating Activities amounts to 112.6m USD.

What is ANI Pharmaceuticals Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
46%

Over the last year, the Cash from Operating Activities growth was 173%. The average annual Cash from Operating Activities growth rates for ANI Pharmaceuticals Inc have been 102% over the past three years , 16% over the past five years , and 46% over the past ten years .

Back to Top